In Vitro Lung Model Market Size, Share & Trends Analysis Report By Type (2D Model, 3D Model), By Application (Physiological Research, 3D Model Development), By End-use, By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED: December 4, 2023

PAGES: 130 Pages

DELIVERY TIME: 2-10 business days

SELECT AN OPTION

The global in vitro lung model market size is expected to reach USD 948.1 million by 2030, growing at a CAGR of 17.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The factors driving market growth include increasing emphasis on creating substitutes for animal testing models, and recent global rise in respiratory-related disorders over the past few years. In vitro lung models help researchers replicate specific respiratory diseases, closely mimicking the cellular and molecular characteristics of these disorders for the development of potential treatment options. Thus, disease modeling contributes to the overall growth of in vitro lung models. Furthermore, as per The Humane Society of the United States (HSUS) report, about 50 million animals are used in experiments each year in the U.S. To mitigate cruelty to animals, the Animal Welfare Act (AWA) has established regulations aimed at reducing harmful experiments on animals.

Thus, over the past few years, there has been a notable global awareness and concern regarding the ethical treatment of animals in the research field. This emphasis has contributed to the increased demand for in vitro lung models worldwide. Furthermore, maintaining and testing on animals is expensive, whereas the use of in vitro models can be more cost-effective, especially for high-throughput screening of compounds and chemicals. This cost-effectiveness is appealing to researchers and organizations with limited budgets, making in vitro models a dependable alternative to animal testing. Key participants are adopting various strategies including partnerships, mergers & acquisitions, agreements, and product launches, to expand their global footprints and product portfolio. For instance, in June 2023, AlveoliX introduced a new organ-on-chip system that includes innovative 3D structure features, making mimicking any organ more convenient.

In Vitro Lung Model Market Report Highlights:

2D model type dominated the market in 2023 due to their convenience, efficiency, and comprehensive nature
The drug discovery & toxicology studies application segment dominated the market in 2023 as these models play a pivotal role in the early stages of pharmaceutical research & development
Based on end-use, the pharmaceutical & biotechnology companies segment dominated the market in 2023 due to their critical role in drug development & research
North America dominated the industry in 2023 owing to the presence of key players as well as academic research institutions in the region
Key players operating in the market constantly focus on product launches, partnerships, and geographical expansions to maintain their market position

Product Code: GVR-4-68040-159-8

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Market Definitions
- 1.2.1. Information Analysis
- 1.2.2. Market Application & Data Visualization
- 1.2.3. Data Validation & Publishing
1.3. Research Assumptions
1.4. Information Procurement
- 1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Application & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
- 1.9.1. Objective 1:
- 1.9.2. Objective 2:

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Rising prevalence of respiratory diseases
  - 3.2.1.2. Advancement in cell culture technology
  - 3.2.1.3. Increasing number of research activities being done towards pulmonary drug development
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Lack of skilled professional
3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

4.1. In Vitro Lung Model Market: Product Movement Analysis
4.2. 2D Model
- 4.2.1. 2D Model Market, 2018 - 2030 (USD Million)
4.3. 3D Model
- 4.3.1. 3D Model Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

5.1. In Vitro Lung Model Market: Application Movement Analysis
5.2. Drug discovery and Toxicology Studies
- 5.2.1. Drug discovery and toxicology studies Market, 2018 - 2030 (USD Million)
5.3. Physiological Research
- 5.3.1. Physiological Research Market, 2018 - 2030 (USD Million)
5.4. 3D Model Development
- 5.4.1. 3D Model Development Market, 2018 - 2030 (USD Million)
5.5. Others
- 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

6.1. In Vitro Lung Model Market: End-use Movement Analysis
6.2. Academic Research Institutes
- 6.2.1. Academic Research Institutes Market, 2018 - 2030 (USD Million)
6.3. Pharmaceutical and Biotechnology Companies
- 6.3.1. Pharmaceutical and Biotechnology Companies Market, 2018 - 2030 (USD Million)
6.4. Others
- 6.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

7.1. In Vitro Lung Model Market Share By Region, 2023 & 2030
7.2. North America
- 7.2.1. North America In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
  - 7.2.2.1. Key Country Dynamics
  - 7.2.2.2. Competitive Scenario
  - 7.2.2.3. Regulatory Framework
  - 7.2.2.4. U.S. In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.2.3. Canada
  - 7.2.3.1. Key Country Dynamics
  - 7.2.3.2. Competitive Scenario
  - 7.2.3.3. Regulatory Framework
  - 7.2.3.4. Canada In Vitro Lung Model Market, 2018 - 2030 (USD Million)
7.3. Europe
- 7.3.1. Europe In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.3.2. UK
  - 7.3.2.1. Key Country Dynamics
  - 7.3.2.2. Competitive Scenario
  - 7.3.2.3. Regulatory Framework
  - 7.3.2.4. UK In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.3.3. Germany
  - 7.3.3.1. Key Country Dynamics
  - 7.3.3.2. Competitive Scenario
  - 7.3.3.3. Regulatory Framework
  - 7.3.3.4. Germany In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.3.4. France
  - 7.3.4.1. Key Country Dynamics
  - 7.3.4.2. Competitive Scenario
  - 7.3.4.3. Regulatory Framework
  - 7.3.4.4. France In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.3.5. Italy
  - 7.3.5.1. Key Country Dynamics
  - 7.3.5.2. Competitive Scenario
  - 7.3.5.3. Regulatory Framework
  - 7.3.5.4. Italy In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.3.6. Spain
  - 7.3.6.1. Key Country Dynamics
  - 7.3.6.2. Competitive Scenario
  - 7.3.6.3. Regulatory Framework
  - 7.3.6.4. Spain In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.3.7. Denmark
  - 7.3.7.1. Key Country Dynamics
  - 7.3.7.2. Competitive Scenario
  - 7.3.7.3. Regulatory Framework
  - 7.3.7.4. Denmark In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.3.8. Sweden
  - 7.3.8.1. Key Country Dynamics
  - 7.3.8.2. Competitive Scenario
  - 7.3.8.3. Regulatory Framework
  - 7.3.8.4. Sweden In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.3.9. Norway
  - 7.3.9.1. Key Country Dynamics
  - 7.3.9.2. Competitive Scenario
  - 7.3.9.3. Regulatory Framework
  - 7.3.9.4. Norway In Vitro Lung Model Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
- 7.4.1. Asia Pacific In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.4.2. Japan
  - 7.4.2.1. Key Country Dynamics
  - 7.4.2.2. Competitive Scenario
  - 7.4.2.3. Regulatory Framework
  - 7.4.2.4. Japan In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.4.3. China
  - 7.4.3.1. Key Country Dynamics
  - 7.4.3.2. Competitive Scenario
  - 7.4.3.3. Regulatory Framework
  - 7.4.3.4. China In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.4.4. India
  - 7.4.4.1. Key Country Dynamics
  - 7.4.4.2. Competitive Scenario
  - 7.4.4.3. Regulatory Framework
  - 7.4.4.4. India In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.4.5. Australia
  - 7.4.5.1. Key Country Dynamics
  - 7.4.5.2. Competitive Scenario
  - 7.4.5.3. Regulatory Framework
  - 7.4.5.4. Australia In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.4.6. Thailand
  - 7.4.6.1. Key Country Dynamics
  - 7.4.6.2. Competitive Scenario
  - 7.4.6.3. Regulatory Framework
  - 7.4.6.4. Thailand In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.4.7. South Korea
  - 7.4.7.1. Key Country Dynamics
  - 7.4.7.2. Competitive Scenario
  - 7.4.7.3. Regulatory Framework
  - 7.4.7.4. South Korea In Vitro Lung Model Market, 2018 - 2030 (USD Million)
7.5. Latin America
- 7.5.1. Latin America In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. Competitive Scenario
  - 7.5.2.3. Regulatory Framework
  - 7.5.2.4. Brazil In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.5.3. Mexico
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Competitive Scenario
  - 7.5.3.3. Regulatory Framework
  - 7.5.3.4. Mexico In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.5.4. Argentina
  - 7.5.4.1. Key Country Dynamics
  - 7.5.4.2. Competitive Scenario
  - 7.5.4.3. Regulatory Framework
  - 7.5.4.4. Argentina In Vitro Lung Model Market, 2018 - 2030 (USD Million)
7.6. MEA
- 7.6.1. MEA In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.6.2. South Africa
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Competitive Scenario
  - 7.6.2.3. Regulatory Framework
  - 7.6.2.4. South Africa In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.6.3. Saudi Arabia
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. Competitive Scenario
  - 7.6.3.3. Regulatory Framework
  - 7.6.3.4. Saudi Arabia In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.6.4. UAE
  - 7.6.4.1. Key Country Dynamics
  - 7.6.4.2. Competitive Scenario
  - 7.6.4.3. Regulatory Framework
  - 7.6.4.4. UAE In Vitro Lung Model Market, 2018 - 2030 (USD Million)
- 7.6.5. Kuwait
  - 7.6.5.1. Key Country Dynamics
  - 7.6.5.2. Competitive Scenario
  - 7.6.5.3. Regulatory Framework
  - 7.6.5.4. Kuwait In Vitro Lung Model Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles
- 8.4.1. Epithelix
  - 8.4.1.1. Overview
  - 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Strategic Initiatives
- 8.4.2. MATTEK
  - 8.4.2.1. Overview
  - 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Strategic Initiatives
- 8.4.3. MIMETAS
  - 8.4.3.1. Overview
  - 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Strategic Initiatives
- 8.4.4. Lonza
  - 8.4.4.1. Overview
  - 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Strategic Initiatives
- 8.4.5. Emulate
  - 8.4.5.1. Overview
  - 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Strategic Initiatives
- 8.4.6. AlveoliX AG
  - 8.4.6.1. Overview
  - 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Strategic Initiatives
- 8.4.7. InSphero
  - 8.4.7.1. Overview
  - 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Strategic Initiatives
- 8.4.8. CN Bio Innovations Ltd
  - 8.4.8.1. Overview
  - 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Strategic Initiatives
- 8.4.9. ATTC Global
  - 8.4.9.1. Overview
  - 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Strategic Initiatives
- 8.4.10. TissUse GmbH
  - 8.4.10.1. Overview
  - 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.10.3. Product Benchmarking
  - 8.4.10.4. Strategic Initiatives

Product Code: GVR-4-68040-159-8

List of Tables

TABLE 1 Global In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 2 Global In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 3 Global In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 4 Global In Vitro Lung Model market, by region, 2018 - 2030 (USD Million)
TABLE 5 North America In Vitro Lung Model market, by country, 2018 - 2030 (USD Million)
TABLE 6 North America In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 7 North America In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 8 North America In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 9 U.S. In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 10 U.S. In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 11 U.S. In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 12 Canada In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 13 Canada In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 14 Canada In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 15 Europe In Vitro Lung Model market, by country, 2018 - 2030 (USD Million)
TABLE 16 Europe In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 17 Europe In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 18 Europe In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 19 UK In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 20 UK In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 21 UK In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 22 Germany In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 23 Germany In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 24 Germany In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 25 France In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 26 France In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 27 France In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 28 Italy In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 29 Italy In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 30 Italy In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 31 Spain In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 32 Spain In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 33 Spain In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 34 Sweden In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 35 Sweden In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 36 Sweden In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 37 Norway In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 38 Norway In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 39 Norway In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 40 Denmark In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 41 Denmark In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 42 Denmark In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 43 Asia Pacific In Vitro Lung Model market, by country, 2018 - 2030 (USD Million)
TABLE 44 Asia Pacific In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 45 Asia Pacific In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 46 Asia Pacific In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 47 Japan In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 48 Japan In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 49 Japan In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 50 China In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 51 China In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 52 China In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 53 India In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 54 India In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 55 India In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 56 Australia In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 57 Australia In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 58 Australia In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 59 South Korea In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 60 South Korea In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 61 South Korea In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 62 Thailand In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 63 Thailand In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 64 Thailand In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 65 Latin America In Vitro Lung Model market, by country, 2018 - 2030 (USD Million)
TABLE 66 Latin America In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 67 Latin America In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 68 Latin America In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 69 Brazil In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 70 Brazil In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 71 Brazil In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 72 Mexico In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 73 Mexico In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 74 Mexico In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 75 Argentina In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 76 Argentina In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 77 Argentina In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 78 MEA In Vitro Lung Model market, by country, 2018 - 2030 (USD Million)
TABLE 79 MEA In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 80 MEA In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 81 MEA In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 82 South Africa In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 83 South Africa In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 84 South Africa In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 85 Saudi Arabia In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 86 Saudi Arabia In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 87 Saudi Arabia In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 88 UAE In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 89 UAE In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 90 UAE In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 91 Kuwait In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
TABLE 92 Kuwait In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
TABLE 93 Kuwait In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
TABLE 94 Key companies undertaking acquisitions
TABLE 95 Key companies launching new products/services
TABLE 96 Key companies undertaking collaborations and partnerships
TABLE 97 Key companies undertaking other initiatives

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain-based sizing & forecasting
FIG. 6 Market formulation & validation
FIG. 7 In Vitro Lung Model market segmentation
FIG. 8 Market snapshot, 2023
FIG. 9 Market trends & outlook
FIG. 10 Market driver relevance analysis (current & future impact)
FIG. 11 Market restraint relevance analysis (current & future impact)
FIG. 12 SWOT analysis, by factor (political & legal, economic, and technological)
FIG. 13 Porter's five forces analysis
FIG. 14 Global In Vitro Lung Model Market: Type movement analysis
FIG. 15 Global In Vitro Lung Model Market, for 2D Model, 2018 - 2030 (USD Million)
FIG. 16 Global In Vitro Lung Model Market, for 3D Model, 2018 - 2030 (USD Million)
FIG. 17 Global In Vitro Lung Model Market: application movement analysis
FIG. 18 Global In Vitro Lung Model Market, for drug discovery and toxicology studies, 2018 - 2030 (USD Million)
FIG. 19 Global In Vitro Lung Model Market, for 3D model development, 2018 - 2030 (USD Million)
FIG. 20 Global In Vitro Lung Model Market, for others, 2018 - 2030 (USD Million)
FIG. 21 Global In Vitro Lung Model Market: end-use movement analysis
FIG. 22 Global In Vitro Lung Model Market, for academic research institutes, 2018 - 2030 (USD Million)
FIG. 23 Global In Vitro Lung Model Market, for pharmaceutical and biotechnology companies, 2018 - 2030 (USD Million)
FIG. 24 Global In Vitro Lung Model Market, for others, 2018 - 2030 (USD Million)
FIG. 25 Regional marketplace: Key takeaways
FIG. 26 Regional outlook, 2023 & 2030
FIG. 27 Global In Vitro Lung Model Market: Region movement analysis
FIG. 28 North America In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 29 U.S. In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 30 Canada In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 31 Europe In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 32 Germany In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 33 UK In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 34 France In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 35 Italy In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 36 Spain In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 37 Denmark In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 38 Sweden In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 39 Norway In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 40 Asia Pacific In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 41 Japan In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 42 China In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 43 India In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 44 Australia In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 45 South Korea In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 46 Thailand In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 47 Latin America In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 48 Brazil In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 49 Mexico In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 50 Argentina In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 51 Middle East and Africa In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 52 South Africa In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 53 Saudi Arabia In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 54 UAE In Vitro Lung Model Market, 2018 - 2030 (USD Million)
FIG. 55 Kuwait In Vitro Lung Model Market, 2018 - 2030 (USD Million)